PrimeRFP SCOUT · Federal Contract Recompete Brief

HT001422F0149Leuko-reduced (white BLOOD CELLS ARE — American National Red Cross, the

American National Red Cross, the holds $80.4M across 322 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent HT001418A0029. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Sep 29, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Defense Health Agency

Awarding office

American National Red Cross, the

Recipient

Sep 29, 2022

PoP end

$579K

Obligated

$579K

Potential

325413

NAICS

6550

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs American National Red Cross, the — $90

Contract facts

NONE

Contract numberHT001422F0149

Also listed asHT0014-22-F-0149

Also listed asHT001418A0029-HT001422F0149

AgencyDefense Health Agency

Awarding officeDefense Health Agency

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentAmerican National Red Cross, the

CAGE7D348

UEIG69LHXJ3ABL5

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDVHT001418A0029

Place of performanceBETHESDA MD

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startSep 29, 2022

PoP end (current)Sep 29, 2022

Obligated$579K

Current value$579K

Potential value$579K

LEUKO-REDUCED (WHITE BLOOD CELLS ARE INTENTIONALLY REDUCED) RED BLOOD CELLS AND APHERESIS (BLOOD CLOTTING) PLATELETS. is a federal NONE award for Defense Health Agency held by American National Red Cross, the. Estimated value $579K ($579K obligated). Current period of performance ends Sep 29, 2022. Last award drew 1 bidder. Place of performance: BETHESDA MD.

LEUKO-REDUCED (WHITE BLOOD CELLS ARE INTENTIONALLY REDUCED) RED BLOOD CELLS AND APHERESIS (BLOOD CLOTTING) PLATELETS.

Recompete timing

Public

● Past PoP end (1422 days ago)

Current PoP ended Sep 29, 2022 (1422 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

American National Red Cross, the — $80.4M obligated across 322 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($80.4M) · all agencies

Department of Veterans Affairs (VA)$57.4M · 71%Department of Defense (DOD)$19.6M · 24%Department of Health and Human Services (HHS)$3.3M · 4%Department of Homeland Security (DHS)$22K · 0%

Open full company profile →

Related awards

Same parent · incumbent

HT001126FE010

MULTIPLE BLOOD PRODUCTS

$1.5M

Sep 30, 2026

HT001126FE012

MULTIPLE BLOOD PRODUCTS

$1.5M

Sep 30, 2026

36C26326N0019

MINNEAPOLIS VAMC BLOOD BANK PRODUCTS AND SERVICES OP1 ORDER

$1.1M

Sep 30, 2026

36C24826N0038

BLOOD PRODUCTS AND BLOOD COMPONENTS FOR VACHS FY26 DO

$960K

Sep 30, 2026

36C25026N0035

BLOOD, BLOOD PRODUCTS, AND REFERENCE LAB SERVICES - YEAR 3

$780K

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HT001422F0149?

HT001422F0149 (Leuko-reduced (white BLOOD CELLS ARE) is a Defense Health Agency award with a potential value of $579K, currently held by American National Red Cross, the. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT0014-22-F-0149?

HT0014-22-F-0149 is the dashed form of PIID HT001422F0149 (Leuko-reduced (white BLOOD CELLS ARE), held by American National Red Cross, the. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT001422F0149?

Defense Health Agency awarded HT001422F0149 to American National Red Cross, the (potential $579K).

Who is the incumbent on HT001422F0149?

American National Red Cross, the is the incumbent with $80.4M across 322 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2022.

When does American National Red Cross, the’s HT001422F0149 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Jul 11, 2023